Table 1.

Multivariate analyses

Covariate	Cox proportional HR (95% CI)	Adjusted p-value
Molecular subgroup (HPV+/HPV−p53wt/HPV−p53mut)	1.364 (0.515–3.613)	0.532
Stage (early/late)	2.120 (0.643–6.990)	0.217
Epithelium CD3+ total (low/high)	0.078 (0.009–0.638)	0.017
Epithelium CD14+rest− (low/high)	0.077 (0.010–0.591)	0.014

Covariate	Cox proportional HR (95% CI)	Adjusted p-value
Molecular subgroup (HPV+/HPV−p53wt/HPV−p53mut)	1.317 (0.507–3.423)	0.572
Stage (early/late)	1.574 (0.475–5.213)	0.458
Epithelium CD3+ total (low/high)	0.112 (0.014–0.925)	0.042
Stroma HLADR+CD11c+CD14+rest− (low/high)	0.121 (0.015–0.964)	0.046

Covariate	Cox proportional HR (95% CI)	Adjusted p-value
Molecular subgroup (HPV+/HPV−p53wt/HPV−p53mut)	1.177 (0.431–3.219)	0.750
Stage (early/late)	2.150 (0.651–7.096)	0.209
Epithelium CD3+ total (low/high)	0.079 (0.009–0.670)	0.020
Epithelium CD14+rest− (low/high)	0.113 (0.014–0.939)	0.044
Stroma HLADR+CD11c+CD14+rest− (low/high)	0.315 (0.037–2.704)	0.292

Bold values indicate the adjusted p-values that are < 0.05